Comment on "Association of GLP-1 Receptor Agonist Use With Risk of Lumbar Degenerative Disease and Spine Surgery in Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study". [PDF]
Li X, Cai Y, Zeng Q.
europepmc +1 more source
Combination of GLP-1 receptor agonist and Akkermansia muciniphila Akk11 reduces adiposity and ameliorates MASLD in T2D mice. [PDF]
Gao K +13 more
europepmc +1 more source
Intractable Vomiting in the Setting of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist and Cannabis Usage. [PDF]
DesRochers P +4 more
europepmc +1 more source
GLP-1 Receptor Agonist Indications and Prescriptions Among Adults Who Do and Do Not Smoke. [PDF]
Leavens ELS +5 more
europepmc +1 more source
GLP-1 Receptor Agonist Therapy and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 Diabetes. [PDF]
Chen JC +4 more
europepmc +1 more source
Decoding incretin resistance: a mechanistic framework to reclassify therapeutic variability for GLP-1 receptor agonist therapy. [PDF]
Fajkić A, Lam YW, Belančić A.
europepmc +1 more source
Added Value to GLP-1 Receptor Agonist: Intermittent Fasting and Lifestyle Modification to Improve Therapeutic Effects and Outcomes. [PDF]
Cozma D, Văcărescu C, Stoicescu C.
europepmc +1 more source
Preoperative GLP-1 Receptor Agonist Use Is Not Associated With Complications in Non-Obese Patients Undergoing Total Shoulder Arthroplasty: A Propensity Score Matched Large Database Analysis. [PDF]
White AE +4 more
europepmc +1 more source
Systematic Review Evaluating the Effects of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use on the Postoperative Outcomes of Patients Undergoing Arthroplasty Procedures. [PDF]
Tabor H +4 more
europepmc +1 more source

